Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927834 · ClinicalTrials.gov registry record · NA
Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02927834 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 24 participants.
The verdict
NCT02927834, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Chronic rhinosinusitis is a common disease that effects millions of people world wide. Despite its frequency it is unclear what treatment options are the best for these patients. Typically patients with chronic rhinosinusitis without nasal polyps (CRSsNP) are given a long term antibiotic (3 weeks), nasal steroid sprays, saline nasal irrigation and occasionally oral steroids. Oral steroids benefit patients with chronic rhinosinusitis with nasal polyps (CRSwNP) however their role in non polyp patients is less clear. It is the goal of this study to see if oral steroids benefit the treatment outcomes in those patients with chronic rhinosinusitis without nasal polyps. In addition this study will look to see if a short course (5 day burst) versus a longer course (21 day taper) of oral steroids make a difference in outcomes.
Interventions
- DRUG Augmentin
- DRUG 6 day Prednisone
- DRUG 21 day Prednisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927834
The ClinicalTrials.gov registry entry for NCT02927834 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Augmentin is the first listed.
NCT02927834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02927834 about?
NCT02927834 is a clinical study titled "Oral Steroids in Chronic Rhinosinusitis Without Nasal Polyps". Chronic rhinosinusitis is a common disease that effects millions of people world wide. Despite its frequency it is unclear what treatment options are the best for these patients. Typically patients with chronic rhinosinusitis without nasal polyps (CRSsNP) are given a long term antibiotic (3 weeks), ...
What is the current status of trial NCT02927834?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-08. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02927834?
The interventions under investigation include: Augmentin (DRUG), 6 day Prednisone (DRUG), 21 day Prednisone (DRUG).
Who is sponsoring clinical trial NCT02927834?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.